Alliancebernstein L.P. Sells 3,472,895 Shares of Astera Labs, Inc. $ALAB

Alliancebernstein L.P. cut its position in Astera Labs, Inc. (NASDAQ:ALAB) by 54.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 2,918,685 shares of the company’s stock after selling 3,472,895 shares during the quarter. Alliancebernstein L.P.’s holdings in Astera Labs were worth $571,479,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Assetmark Inc. grew its holdings in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Clearstead Trust LLC increased its position in shares of Astera Labs by 46,100.0% during the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after acquiring an additional 461 shares in the last quarter. Advisors Asset Management Inc. raised its holdings in Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after acquiring an additional 194 shares during the last quarter. Manchester Capital Management LLC raised its holdings in Astera Labs by 141.5% in the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after acquiring an additional 283 shares during the last quarter. Finally, Pinpoint Asset Management Singapore Pte. Ltd. bought a new position in Astera Labs in the 3rd quarter valued at approximately $47,000. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $117.47, for a total value of $1,174,700.00. Following the transaction, the general counsel directly owned 128,084 shares of the company’s stock, valued at approximately $15,046,027.48. This trade represents a 7.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief operating officer owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This represents a 5.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 224,292 shares of company stock valued at $27,676,069 over the last ninety days. 12.50% of the stock is owned by insiders.

Astera Labs Trading Up 0.3%

NASDAQ:ALAB opened at $120.31 on Friday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The company has a market cap of $20.48 billion, a PE ratio of 98.61, a price-to-earnings-growth ratio of 2.37 and a beta of 1.74. The company has a 50 day simple moving average of $147.89 and a two-hundred day simple moving average of $168.11.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have commented on ALAB. Morgan Stanley reiterated an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a research note on Wednesday, December 3rd. Raymond James Financial assumed coverage on Astera Labs in a report on Friday, November 21st. They set a “hold” rating on the stock. Citigroup dropped their price objective on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Royal Bank Of Canada assumed coverage on Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective for the company. Finally, Loop Capital began coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $202.22.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.